Published in BMC Cancer on December 03, 2010
Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci (2012) 1.45
The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol (2013) 1.16
Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol (2011) 1.14
Inflammation and cancer. World J Gastrointest Surg (2012) 1.12
TLR4 is a novel determinant of the response to paclitaxel in breast cancer. Mol Cancer Ther (2013) 1.11
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol (2011) 1.10
Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res (2014) 1.08
Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One (2011) 1.04
Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation. J Inflamm (Lond) (2012) 1.03
Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer. PLoS One (2012) 1.03
β-Catenin and NF-κB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ (2014) 1.00
Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis. PLoS One (2014) 0.99
FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4. Nat Commun (2013) 0.99
Toll-like receptor 4 signaling promotes epithelial-mesenchymal transition in human hepatocellular carcinoma induced by lipopolysaccharide. BMC Med (2012) 0.98
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J Exp Clin Cancer Res (2011) 0.98
Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma. PLoS One (2011) 0.97
The Role of TLR4 in Chemotherapy-Driven Metastasis. Cancer Res (2015) 0.95
Links between Toll-like receptor 4 and breast cancer. Oncoimmunology (2013) 0.94
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. Onco Targets Ther (2013) 0.94
Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma. Dig Dis Sci (2013) 0.93
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer (2013) 0.91
Toll-like receptor 9 in breast cancer. Front Immunol (2014) 0.89
DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells. Breast Cancer Res Treat (2013) 0.87
Expression of toll-like receptors on breast tumors: taking a toll on tumor microenvironment. Int J Breast Cancer (2011) 0.87
The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol (2014) 0.86
Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings. Front Immunol (2014) 0.83
Cellular phenotype-dependent and -independent effects of vitamin C on the renewal and gene expression of mouse embryonic fibroblasts. PLoS One (2012) 0.82
Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment. Breast Cancer (Dove Med Press) (2013) 0.81
Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. Oncotarget (2016) 0.80
The dual role of TLR3 in metastatic cell line. Clin Exp Metastasis (2011) 0.80
Is cancer a severe delayed hypersensitivity reaction and histamine a blueprint? Clin Transl Med (2016) 0.79
Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironment. Oncotarget (2016) 0.78
HMGB1 induction of clusterin creates a chemoresistant niche in human prostate tumor cells. Sci Rep (2015) 0.78
Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa. G3 (Bethesda) (2013) 0.78
Mesenchymal stem cells: key players in cancer progression. Mol Cancer (2017) 0.77
A Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer Relapse. PLoS One (2015) 0.77
Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice. PLoS One (2015) 0.77
Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma. Oncotarget (2015) 0.77
TLR3 correlated with cervical lymph node metastasis in patients with papillary thyroid cancer. Int J Clin Exp Med (2014) 0.76
Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. Int J Mol Sci (2016) 0.76
Mucins and toll-like receptors: kith and kin in infection and cancer. Cancer Lett (2012) 0.76
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth. Proc Natl Acad Sci U S A (2015) 0.76
Cell Free DNA of Tumor Origin Induces a 'Metastatic' Expression Profile in HT-29 Cancer Cell Line. PLoS One (2015) 0.76
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth. Nat Commun (2017) 0.75
Decreased expression of Toll-like receptor 4 and 5 during progression of prostate transformation in transgenic adenocarcinoma of mouse prostate mice. J Vet Sci (2015) 0.75
Poly I:C induces collective migration of HaCaT keratinocytes via IL-8. BMC Immunol (2017) 0.75
Bioinformatics analysis of differentially expressed pathways related to the metastatic characteristics of osteosarcoma. Int J Mol Med (2016) 0.75
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling. J Immunol Res (2016) 0.75
The other face of TLR3: A driving force of breast cancer stem cells. Mol Cell Oncol (2015) 0.75
RNA-seq Profiles of Immune Related Genes in the Spleen of Necrotic Enteritis-afflicted Chicken Lines. Asian-Australas J Anim Sci (2015) 0.75
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma. Onco Targets Ther (2017) 0.75
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature (1997) 23.92
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol (2004) 9.38
TLR signaling. Cell Death Differ (2006) 9.24
Toll-like receptors and cancer. Nat Rev Cancer (2008) 4.29
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res (2006) 3.21
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A (2008) 3.19
Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res (2005) 2.91
A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol (2001) 2.87
TLR3 can directly trigger apoptosis in human cancer cells. J Immunol (2006) 2.79
Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev (2009) 2.30
Cancer; a biological approach. I. The processes of control. Br Med J (1957) 2.29
TLR signaling by tumor and immune cells: a double-edged sword. Oncogene (2008) 2.18
Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer (2004) 1.98
Toll-like receptors and acquired immunity. Semin Immunol (2004) 1.79
Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res (2006) 1.69
In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells. Cancer Res (2009) 1.67
Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol (2002) 1.67
NF-kappaB activation in development and progression of cancer. Cancer Sci (2007) 1.67
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron (2009) 1.60
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis (2008) 1.48
HPV: from infection to cancer. Biochem Soc Trans (2007) 1.47
An innate sense of danger. Ann N Y Acad Sci (2002) 1.47
Molecular characterisation of the tumour microenvironment in breast cancer. Eur J Cancer (2008) 1.39
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate (2008) 1.38
Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br J Cancer (2007) 1.27
Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr Opin Gastroenterol (2006) 1.21
Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol (2009) 1.19
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol Cancer Res (2008) 1.18
Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol (2007) 1.17
Role of toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc) (2008) 1.09
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate (2010) 1.08
CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy. Expert Opin Biol Ther (2007) 1.07
Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Res (2009) 1.04
Dendritic cells and cytokines in immune rejection of cancer. Cytokine Growth Factor Rev (2007) 1.04
Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin Cancer Res (2007) 1.03
Toll-like receptors and their role in carcinogenesis and anti-tumor treatment. Cell Mol Biol Lett (2008) 1.00
Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev (2009) 0.99
Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis. Ann Surg Oncol (2009) 0.99
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas. Breast Cancer Res Treat (2009) 0.96
Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth. Cancer Res (2001) 0.96
'Yin and Yang' in inflammation: duality in innate immune cell function and tumorigenesis. Expert Opin Biol Ther (2008) 0.93
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors. Cancer Sci (2010) 0.92
Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol Res Pract (1994) 0.90
[Proteases in cancer progression]. Gac Med Mex (2009) 0.89
Significance of toll-like receptors expression in tumor growth and spreading: a short review. Cancer Microenviron (2008) 0.88
An approach for understanding the inflammation and cancer relationship. Immunol Lett (2009) 0.87
TLR3 and TLR4 expression in healthy and diseased human endometrium. Reprod Biol Endocrinol (2008) 0.86
Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery (1995) 0.85
[Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)]. Chirurgie (1980) 0.78
[Stromal proteases in the progression of breast cancer]. Bull Mem Acad R Med Belg (1997) 0.78
Stroma -- regulator of cancer cell progression. Exp Oncol (2009) 0.77
[The effect of the microenvironment of head and neck cancers on tumor progression]. Magy Onkol (2009) 0.77
Stroma-mediated expression of estrogen and its role in cancer. Front Biosci (Landmark Ed) (2010) 0.77
RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II. Nature (2011) 1.79
Study of the expression of toll-like receptors in different histological types of colorectal polyps and their relationship with colorectal cancer. J Clin Immunol (2012) 1.50
Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer (2008) 1.48
Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci (2012) 1.45
Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci (2006) 1.19
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother (2010) 1.14
Inflammation and cancer. World J Gastrointest Surg (2012) 1.12
Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol (2013) 1.05
Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology (2013) 1.04
Nucleosomal organization of replication origins and meiotic recombination hotspots in fission yeast. EMBO J (2011) 1.04
Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer. PLoS One (2012) 1.03
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development. PLoS One (2012) 1.00
Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol (2007) 0.97
Contribution of nurses to the quality of care in management of inflammatory bowel disease: a synthesis of the evidence. J Crohns Colitis (2010) 0.96
Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. Hepatol Res (2013) 0.95
Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother (2014) 0.90
High within-day variability of fecal calprotectin levels in patients with active ulcerative colitis: what is the best timing for stool sampling? Inflamm Bowel Dis (2015) 0.88
Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. Hum Pathol (2009) 0.88
Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance. Breast Cancer Res Treat (2005) 0.88
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis. Oncoimmunology (2013) 0.87
Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab. Gut (2008) 0.86
Delphi consensus statement: Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis (2013) 0.85
CD44s expression in resectable colorectal carcinomas and surrounding mucosa. Cancer Invest (2004) 0.85
Toll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancer. J Immunother (2013) 0.85
Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer. Breast Cancer Res Treat (2006) 0.84
Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast. Hum Pathol (2010) 0.84
Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat (2006) 0.82
Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node. Eur J Cancer (2012) 0.82
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol (2002) 0.81
Vulval squamous cell carcinoma arising in localized Darier's disease. Eur J Obstet Gynecol Reprod Biol (2002) 0.81
Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer. J Cancer Res Clin Oncol (2010) 0.81
Relationship between arterial vascular calcifications seen on screening mammograms and biochemical markers of endothelial injury. Eur J Radiol (2007) 0.81
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas. Histopathology (2010) 0.81
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas. Int J Clin Oncol (2012) 0.80
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer. J Cancer Res Clin Oncol (2009) 0.80
Reading virtual slide using web viewers: results of subjective experience with three different solutions. Diagn Pathol (2008) 0.80
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. BMC Cancer (2010) 0.79
Expression and prognostic significance of lysozyme in male breast cancer. Breast Cancer Res (2002) 0.79
Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease. Scand J Gastroenterol (2006) 0.79
The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol (2006) 0.78
Development of quality standards in inflammatory bowel disease management and design of an evaluation tool of nursing care. Rev Esp Enferm Dig (2013) 0.78
[Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease]. Med Clin (Barc) (2007) 0.78
Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. Dig Dis Sci (2012) 0.78
Fecal Calprotectin Levels Are Closely Correlated with the Absence of Relevant Mucosal Lesions in Postoperative Crohn's Disease. Inflamm Bowel Dis (2016) 0.77
alpha(1)-Antichymotrypsin deficiency associated with liver cirrhosis. Pediatr Int (2010) 0.76
Clinical significance of myosin in colorectal cancer. Ann Diagn Pathol (2012) 0.76
CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified. Am J Surg Pathol (2016) 0.76
Analysis of the expression of interleukins, interferon β, and nuclear factor-κ B in prostate cancer and their relationship with biochemical recurrence. J Immunother (2014) 0.76
Addition of mesalazine for subclinical post-surgical endoscopic recurrence of Crohn's disease despite preventive thiopurine therapy: A case-control study. J Gastroenterol Hepatol (2014) 0.76
Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. J Gastrointestin Liver Dis (2011) 0.76
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer. World J Urol (2010) 0.76
Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Transl Oncol (2006) 0.76
Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis. Diagn Pathol (2014) 0.75
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids. Ophthalmologica (2004) 0.75
Relationship between breast arterial calcifications seen on screening mammograms and age-related macular degeneration. Acta Ophthalmol (2014) 0.75
Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). J Cancer Res Clin Oncol (2005) 0.75